IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations-Reference-Cited by-同舟云学术

IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations

Published:2019-12-03 Issue:3 Volume:30 Page:541-553
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:Brain Pathol

Author:

Yang Rui Ryan¹²^ORCID,Shi Zhi‐feng³,Zhang Zhen‐yu⁴,Chan Aden Ka‐Yin²,Aibaidula Abudumijiti³,Wang Wei‐wei⁵,Kwan Johnny Sheung Him²,Poon Wai Sang⁶,Chen Hong⁷,Li Wen‐cai⁵,Chung Nellie Yuk‐Fei²,Punchhi Gopika²,Chu William Ching‐Yuen²,Chan Ivan Sik‐Hei²,Liu Xian‐zhi⁴,Mao Ying³,Li Kay Ka‐Wai²^ORCID,Ng Ho‐Keung²

Affiliation:

1. Department of Neurosurgery Guangzhou Women and Children's Medical Center Guangzhou China

2. Department of Anatomical and Cellular Pathology The Chinese University of Hong Kong Prince of Wales Hospital Shatin Hong Kong, China SAR

3. Department of Neurosurgery Huashan Hospital Fudan University Shanghai China

4. Department of Neurosurgery The First Affiliated Hospital of Zhengzhou University Zhengzhou China

5. Department of Pathology The First Affiliated Hospital of Zhengzhou University Zhengzhou China

6. Department of Neurosurgery The Chinese University of Hong Kong Prince of Wales Hospital Shatin Hong Kong, China SAR

7. Department of Pathology Huashan Hospital Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Neurology (clinical),Pathology and Forensic Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bpa.12801

Reference40 articles.

1. Adult IDH wild-type lower-grade gliomas should be further stratified

2. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas

3. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

4. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

5. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant;Neurosurgical Review;2024-08-09

2. Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single‐center retrospective study;Cancer Medicine;2024-07

3. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?;Neuro-Oncology;2024-06-24

4. The Molecular Landscape of Primary CNS Lymphomas (PCNSLs) in Children and Young Adults;Cancers;2024-04-29

5. Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells;Metabolites;2024-04-25